Adding Imfinzi (durvalumab) to Bacillus Calmette-Guérin (BCG) therapy helped patients with high-risk, non-muscle invasive ...

For patients with HRRm prostate cancer receiving Akeega and Zytiga with prednisone, quality of life remained at baseline.

Crawford, a medical oncologist at Duke Cancer Center and Duke Cancer Center Thoracic Clinic in Durham, North Carolina, ...

Long-term follow-up of the BFR14 trial showed that Gleevec (imatinib) remains effective in advanced gastrointestinal stromal ...

Imfinzi plus FLOT chemotherapy significantly improves overall survival in resectable G/GEJ adenocarcinoma compared to placebo ...

Tagrisso combined with chemotherapy improved overall survival in EGFR-mutated NSCLC patients, including those with poor ...

The combination of Lenvima (lenvatinib) and Keytruda (pembrolizumab) with chemotherapy did not help patients with metastatic ...

Among patients with metastatic cancer who are receiving oral targeted therapy, home-based supervised physical therapy has ...

Stephanie Wachtel told CURE that areola tattooing after HER2-positive breast cancer helped her feel whole again and reconnect ...

The addition of Tecentriq to BCG therapy did not significantly improve outcomes for patients with non–muscle-invasive bladder ...

For patients with myelofibrosis who had anemia at diagnosis and received erythropoiesis-stimulating agents (ESAs) or danazol ...

AI and SPARK platform integration accelerates cancer research by analyzing diverse health data for early detection and ...